An FDA advisory panel has narrowly voted to allow compounding pharmacies to manufacture unapproved peptides, including BPC-157 and KPV, with the recommendation of health secretary Robert F. Kennedy Jr.
A Food and Drug Administration advisory panel narrowly rejected manufacturing of the peptide emideltide but recommended allowing pharmacies to make four other peptides, including epitalon.
The U.S. health officials are investigating a new outbreak involving the diarrhea-causing parasite cyclospora, which has affected at least 72 people as of Wednesday.
The European Medicines Agency (EMA) is taking 'rapid action' to ensure that study results are made public as required by law, following a recent analysis found results for less than half of the studies registered in a key European database were reported within the required time frame.
Starting January 1, 2027, obstetricians and midwives will shift from a bundled global payment system to a fee-for-service model for maternity care services.
According to a new poll, more than a quarter of all U.S. workers say they want to leave their current job but won't because they want to keep their health benefits.
Digital mental health platform Headspace has launched new clinical care partnerships with Charlie Health, Cortica, Prosper Health, and Equip to address specialized behavioral interventions.
A new study finds that job dissatisfaction and health care access uncertainty are growing in the US, with recent reports highlighting the need for better rural health models.
The Federal Trade Commission has settled a lawsuit against CVS Caremark, one of the largest pharmacy benefit managers in the US, over allegations that the company artificially inflated the price of insulin and impeded access to the lifesaving diabetes treatment.